This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Pressmeddelanden
Non-regulatory
Non-regulatory
Redsense Medical announces a strong start of Q4 with incoming order valued over 2 MSEK
Regulatory
Redsense receives SEK 500,000 in funding from Vinnova to develop AI-driven wound monitoring software
Non-regulatory
Redsense Medical announces new project with European Nurses Association
Non-regulatory
Increased use of the Redsense device at top US dialysis providers
Regulatory